These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34057870)

  • 21. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.
    Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?].
    Pan Y; Han R; He Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1131-1134. PubMed ID: 33081905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
    Saik OV; Klimontov VV
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
    Drucker DJ
    Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cell receptors: potential drug targets to combat COVID-19.
    Raghav PK; Kalyanaraman K; Kumar D
    Amino Acids; 2021 Jun; 53(6):813-842. PubMed ID: 33950300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repurposing strategies and key challenges for COVID-19 management.
    Mule S; Singh A; Greish K; Sahebkar A; Kesharwani P; Shukla R
    J Drug Target; 2022 Apr; 30(4):413-429. PubMed ID: 34854327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes.
    Mercado-Gómez M; Prieto-Fernández E; Goikoetxea-Usandizaga N; Vila-Vecilla L; Azkargorta M; Bravo M; Serrano-Maciá M; Egia-Mendikute L; Rodríguez-Agudo R; Lachiondo-Ortega S; Lee SY; Eguileor Giné A; Gil-Pitarch C; González-Recio I; Simón J; Petrov P; Jover R; Martínez-Cruz LA; Ereño-Orbea J; Delgado TC; Elortza F; Jiménez-Barbero J; Nogueiras R; Prevot V; Palazon A; Martínez-Chantar ML
    Commun Biol; 2022 Aug; 5(1):827. PubMed ID: 35978143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of ACE2 in COVID-19].
    Imai Y
    Nihon Yakurigaku Zasshi; 2022; 157(2):115-118. PubMed ID: 35228442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
    Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
    Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.
    Wiernsperger N; Al-Salameh A; Cariou B; Lalau JD
    Diabetes Metab; 2022 Jul; 48(4):101359. PubMed ID: 35662580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End?
    Krejner-Bienias A; Grzela K; Grzela T
    Arch Immunol Ther Exp (Warsz); 2021 Feb; 69(1):1. PubMed ID: 33527308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings.
    Taheri R; Shahrokhi SZ; Amjadi Z; Kazerouni F
    Endocrinol Diabetes Metab; 2023 Sep; 6(5):e441. PubMed ID: 37431844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
    Lally MA; Tsoukas P; Halladay CW; O'Neill E; Gravenstein S; Rudolph JL
    J Am Med Dir Assoc; 2021 Jan; 22(1):193-198. PubMed ID: 33232684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.
    Phyu Khin P; Cha SH; Jun HS; Lee JH
    Med Hypotheses; 2020 Nov; 144():110186. PubMed ID: 33254506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.